Corient Private Wealth’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding OBIO
Corient Private Wealth's OBIO Position: Q3 2026 in Review
Corient Private Wealth opened a new position in Orchestra BioMed (OBIO) in Q3 2026: 10,468 shares worth $65.1K. The stake represents ﹤0.01% of the portfolio and ranks #3189 among its holdings.
93 funds tracked by Wall St. Rank hold OBIO as of Q3 2026.
- Corient Private Wealth held 10,468 shares of Orchestra BioMed worth $65.1K as of Q3 2026.
- Orchestra BioMed was a new Corient Private Wealth position in Q3 2026.
- Orchestra BioMed made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #3189 holding.
- 93 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2026.
Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.